Trials / Completed
CompletedNCT02366962
A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older
Phase III Study of ASP7374-Open-label Study of Subcutaneous Vaccination of Quadrivalent ASP7374 in Adult Subjects Aged 20 or Older
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- UMN Pharma Inc. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to confirm the safety until Day 29 after injection of a single dose of quadrivalent vaccine ASP7374 in adult subjects aged 20 or older
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ASP7374 | subcutaneous |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2015-02-19
- Last updated
- 2017-09-29
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02366962. Inclusion in this directory is not an endorsement.